Better statistics for HIV/AIDS research
Statistical Issues in AIDS Research
This project aims to create better statistical tools to make HIV/AIDS trials and research faster and clearer for people affected by HIV.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11326627 on NIH RePORTER |
What this research studies
Researchers at the University of Washington are developing improved statistical methods to design and analyze HIV clinical trials, laboratory studies, and epidemic data. They will create tools to make trials more efficient, to detect effects with fewer participants, and to give clearer answers from complex lab assays and surveillance data. These methods are technical and focus on data, modeling, and trial design rather than testing a specific drug or vaccine. Over time, the work is intended to guide how future vaccine and treatment studies are run.
Who could benefit from this research
Good fit: People living with HIV, individuals at risk of HIV, and volunteers for HIV vaccine or treatment trials are the most relevant candidates for research that uses these methods.
Not a fit: People without HIV or those seeking immediate clinical care rather than participating in research are unlikely to directly benefit from this methodological work.
Why it matters
Potential benefit: If successful, these methods could speed up HIV vaccine and treatment studies and help bring safer, more effective options to patients sooner.
How similar studies have performed: Similar statistical innovations have helped make clinical trials for infectious diseases more efficient, so this project builds on established successful approaches.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Hughes, James P — University of Washington
- Study coordinator: Hughes, James P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.